Fredun [FREDUN] vs Sequent Scientific [SEQUENT] Detailed Stock Comparison
Fredun
BSE
Loading...
Sequent Scientific
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Fredun wins in 15 metrics, Sequent Scientific wins in 4 metrics, with 0 ties. Fredun appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Fredun | Sequent Scientific | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 21.05 | 154.18 | Fredun |
| Price-to-Book Ratio | 3.30 | 6.24 | Fredun |
| Debt-to-Equity Ratio | 118.22 | 62.47 | Sequent Scientific |
| PEG Ratio | 0.63 | 1.29 | Fredun |
| EV/EBITDA | 10.78 | 29.36 | Fredun |
| Profit Margin (TTM) | 4.50% | 1.85% | Fredun |
| Operating Margin (TTM) | 12.99% | 7.56% | Fredun |
| EBITDA Margin (TTM) | 12.99% | 7.56% | Fredun |
| Return on Equity | 13.96% | 2.84% | Fredun |
| Return on Assets (TTM) | 4.05% | 1.37% | Fredun |
| Free Cash Flow (TTM) | $-351.69M | $442.73M | Sequent Scientific |
| Dividend Yield | 0.09% | N/A | N/A |
| 1-Year Return | 30.92% | 22.66% | Fredun |
| Price-to-Sales Ratio (TTM) | 1.01 | 2.74 | Fredun |
| Enterprise Value | $6.61B | $48.76B | Sequent Scientific |
| EV/Revenue Ratio | 1.33 | 3.04 | Fredun |
| Gross Profit Margin (TTM) | 26.25% | 46.86% | Sequent Scientific |
| Revenue per Share (TTM) | $1,128 | $64 | Fredun |
| Earnings per Share (Diluted) | $50.32 | $1.14 | Fredun |
| Beta (Stock Volatility) | 0.84 | 0.91 | Fredun |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Fredun vs Sequent Scientific Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Fredun | 0.82% | -2.86% | 16.92% | 52.88% | 50.84% | 42.65% |
| Sequent Scientific | -0.07% | 0.45% | -5.27% | 0.82% | 19.96% | -4.81% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Fredun | 30.92% | 8.95% | 351.36% | 8,277.20% | 8,277.20% | 8,277.20% |
| Sequent Scientific | 22.66% | 59.79% | 34.23% | 19.22% | 19.22% | 19.22% |
Performance & Financial Health Analysis: Fredun vs Sequent Scientific
| Metric | FREDUN | SEQUENT |
|---|---|---|
| Market Information | ||
| Market Cap | ₹5.00B | ₹43.92B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 26,613 | 740,868 |
| 90 Day Avg. Volume | 21,414 | 544,283 |
| Last Close | ₹1,055.75 | ₹175.64 |
| 52 Week Range | ₹635.00 - ₹1,143.00 | ₹117.35 - ₹240.70 |
| % from 52W High | -7.63% | -27.03% |
| All-Time High | ₹1,428.00 (Dec 05, 2022) | ₹336.50 (Jun 28, 2021) |
| % from All-Time High | -26.07% | -47.80% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.52% | 0.13% |
| Quarterly Earnings Growth | 0.64% | 1.20% |
| Financial Health | ||
| Profit Margin (TTM) | 0.05% | 0.02% |
| Operating Margin (TTM) | 0.13% | 0.08% |
| Return on Equity (TTM) | 0.14% | 0.03% |
| Debt to Equity (MRQ) | 118.22 | 62.47 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹321.10 | ₹28.19 |
| Cash per Share (MRQ) | ₹12.65 | ₹2.52 |
| Operating Cash Flow (TTM) | ₹-1,140,997,000 | ₹360.47M |
| Levered Free Cash Flow (TTM) | ₹197.39M | ₹218.78M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.09% | N/A |
| Last 12-Month Dividend | ₹0.70 | ₹0.00 |
Valuation & Enterprise Metrics Analysis: Fredun vs Sequent Scientific
| Metric | FREDUN | SEQUENT |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 21.05 | 154.18 |
| Forward P/E | N/A | 34.81 |
| PEG Ratio | 0.63 | 1.29 |
| Price to Sales (TTM) | 1.01 | 2.74 |
| Price to Book (MRQ) | 3.30 | 6.24 |
| Market Capitalization | ||
| Market Capitalization | ₹5.00B | ₹43.92B |
| Enterprise Value | ₹6.61B | ₹48.76B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.33 | 3.04 |
| Enterprise to EBITDA | 10.78 | 29.36 |
| Risk & Other Metrics | ||
| Beta | 0.84 | 0.91 |
| Book Value per Share (MRQ) | ₹321.10 | ₹28.19 |
Financial Statements Comparison: Fredun vs Sequent Scientific
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | FREDUN | SEQUENT |
|---|---|---|
| Revenue/Sales | ₹1.19B | ₹4.41B |
| Cost of Goods Sold | ₹880.59M | ₹2.35B |
| Gross Profit | ₹313.44M | ₹2.07B |
| Research & Development | ₹0 | N/A |
| Operating Income (EBIT) | ₹155.72M | ₹333.50M |
| EBITDA | ₹169.91M | ₹505.30M |
| Pre-Tax Income | ₹90.40M | ₹255.20M |
| Income Tax | ₹22.75M | ₹79.50M |
| Net Income (Profit) | ₹67.66M | ₹175.70M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | FREDUN | SEQUENT |
|---|---|---|
| Cash & Equivalents | ₹6.37M | ₹626.60M |
| Total Current Assets | ₹4.28B | ₹8.74B |
| Total Current Liabilities | ₹3.21B | ₹5.05B |
| Long-Term Debt | ₹165.35M | ₹3.00B |
| Total Shareholders Equity | ₹1.41B | ₹7.70B |
| Retained Earnings | N/A | ₹1.25B |
| Property, Plant & Equipment | ₹524.89M | ₹2.84B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | FREDUN | SEQUENT |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | FREDUN | SEQUENT |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 26,613 | 740,868 |
| Average Daily Volume (90 Day) | 21,414 | 544,283 |
| Shares Outstanding | 4.72M | 249.89M |
| Float Shares | 2.71M | 117.77M |
| % Held by Insiders | 0.59% | 0.53% |
| % Held by Institutions | 0.00% | 0.13% |
Dividend Analysis & Yield Comparison: Fredun vs Sequent Scientific
| Metric | FREDUN | SEQUENT |
|---|---|---|
| Last 12-Month Dividend | ₹0.70 | ₹0.00 |
| Last 12-Month Dividend Yield | 0.09% | N/A |
| 3-Year Avg Annual Dividend | ₹0.70 | ₹0.00 |
| 3-Year Avg Dividend Yield | 0.08% | N/A |
| 3-Year Total Dividends | ₹2.10 | ₹0.00 |
| Ex-Dividend Date | Sep 23, 2024 | N/A |